Medicare Can Cover Anti-Obesity Drugs for Heart Disease -- But at What Cost?
(MedPage Today) -- On March 8, 2024, FDA approved Wegovy (semaglutide) to treat cardiovascular disease risks -- heart attack, stroke, and death -- for obese or overweight adults with a history of cardiovascular disease, making it the first... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - April 8, 2024 Category: Primary Care Source Type: news
What to do about jaw pain, and when to worry
Jaw pain can be caused by clenching, stress, joint problems and even a heart attack. Here ’s how to figure out what the problem is and what to do. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - April 8, 2024 Category: Consumer Health News Authors: Ashley Abramson Source Type: news
Chelation Flops for Cardio Health After Heart Attack
(MedPage Today) -- ATLANTA -- Chelation to remove lead and other heavy metals didn't improve outcomes for type 2 diabetes patients after myocardial infarction (MI), the TACT2 trial showed.
Cumulative incidence of time to first event (MI, stroke... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - April 8, 2024 Category: Primary Care Source Type: news
Why you should keep taking beta blockers: DR MARTIN SCURR dismisses concerns from a new study
Thousands of people in the UK take beta blockers, not just after a heart attack, but for heart rhythm problems, high blood pressure and anxiety. These drugs can be - and are - lifesaving. (Source: the Mail online | Health)
Source: the Mail online | Health - April 8, 2024 Category: Consumer Health News Source Type: news
Beta-Blockers Fail to Deliver Secondary Prevention Benefit in Key MI Patients
(MedPage Today) -- ATLANTA -- Beta-blockers had no additive benefit over contemporary therapies for people with acute myocardial infarction (MI) maintaining a preserved left ventricular ejection fraction (LVEF), the REDUCE-AMI randomized trial... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 8, 2024 Category: Cardiology Source Type: news
ACC: Empagliflozin Cuts Heart Failure Hospitalization Risk After AMI
MONDAY, April 8, 2024 -- For patients with acute myocardial infarction at risk for heart failure, empagliflozin reduces the risk for heart failure hospitalization, according to a study published online April 6 in Circulation to coincide with the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 8, 2024 Category: Pharmaceuticals Source Type: news
Beta blockers help only HALF of heart attack patients, landmark trial finds
Around 60,000 people are prescribed beta blockers every year in the UK. But a trial has found that, for about half of patients, they do not reduce the risk of death or further heart attacks. (Source: the Mail online | Health)
Source: the Mail online | Health - April 7, 2024 Category: Consumer Health News Source Type: news
Roche and Alnylam present positive results from the Phase II KARDIA-2 study of zilebesiran added to standard of care antihypertensives in patients with inadequately controlled hypertension
The KARDIA-2 study met its primary endpoint demonstrating additive, placebo-adjusted systolic blood pressure reductions of up to 12.1 mmHgat month three. These results were statistically significant and clinically meaningfulZilebesiran demonstrated an encouraging safety and tolerability profile when added to standard of care antihypertensives Basel, 7 April 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and Alnylam today released detailed results from the Phase II KARDIA-2 study evaluating the efficacy and safety of a single subcutaneous dose of zilebesiran when added to one of three standard of care (SOC) antihypertensives. T...
Source: Roche Investor Update - April 7, 2024 Category: Pharmaceuticals Source Type: news
Proof of Benefit in Acute MI Again Evades an SGLT2 Inhibitor
(MedPage Today) -- ATLANTA -- The SGLT2 inhibitor empagliflozin (Jardiance) did not exactly prevent deaths and heart failure (HF) events when initiated atop other standard therapies for acute myocardial infarction (MI), the EMPACT-HF trial found... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 7, 2024 Category: Cardiology Source Type: news
Country Star Colt Ford Hospitalized After Post-Concert Heart Attack
NASHVILLE, TENNESSEE - AUGUST 17: Colt Ford performs at Skydeck at Assembly Food Hall on August 17, 2023 in Nashville, Tennessee. (Photo by Jason Kempin/Getty Images) Country singer and rapper Colt Ford, the cowriter of the hit song Dirt Road Anthem, has been hospitalized after suffering a heart…#nashville #tennessee #coltford #dirtroadanthem #gilbert #ariz #ford #mesa #brantleygilbert #jasonaldean (Source: Reuters: Health)
Source: Reuters: Health - April 6, 2024 Category: Consumer Health News Source Type: news
Why Heart Disease Research Still Favors Men
Published in partnership with The Fuller Project, a nonprofit newsroom dedicated to the coverage of women’s issues around the world.
Katherine Fitzgerald had just arrived at the party. Before she could even get a drink, she threw up and broke out in a sweat. “I was dizzy. I couldn’t breathe. I had heart pain,” Fitzgerald says.
She knew she was having a heart attack.
[time-brightcove not-tgx=”true”]
What she didn’t know then was that the heart attack could have been prevented. Fitzgerald, a health-conscious, exercise-loving lawyer, should have been taking statin drugs to s...
Source: TIME: Health - April 5, 2024 Category: Consumer Health News Authors: Maggie Fox Tags: Uncategorized freelance healthscienceclimate Source Type: news
Have Only Well-Off Americans Gained From Recent Strides Against Heart Disease?
FRIDAY, April 5, 2024 -- America is making headway against heart disease, with heart-related deaths declining over the past three decades.
But it appears that only the well-to-do have benefitted, a new study shows.
Heart attack rates have stayed... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 5, 2024 Category: General Medicine Source Type: news
ACC Meeting to Make Noise on Beta-Blockers, SGLT2i, Chelation Therapy for Acute MI
(MedPage Today) -- ATLANTA -- Those in cardiovascular medicine can anticipate changes in clinical practice for acute myocardial infarction (MI) following this weekend's American College of Cardiology (ACC) annual conference, the first time the... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 5, 2024 Category: Cardiology Source Type: news
Surgeon reveals sign of silent killer that can appear on the head
If you notice this sign on your head you could be at greater risk for a heart attack or stroke. (Source: Daily Express - Health)
Source: Daily Express - Health - April 2, 2024 Category: Consumer Health News Source Type: news
What It Means if You Have Borderline High Cholesterol —And What to Do About It
Almost 25 million adults in the U.S. have high cholesterol, which puts them at a higher risk for a heart attack or stroke in the next decade. But a much bigger portion have what’s called borderline high cholesterol, an in-between place that’s not quite high, but not quite within a normal range.
Here’s what to know about borderline cholesterol.
What is borderline cholesterol?
[time-brightcove not-tgx=”true”]
High cholesterol is defined as having a total cholesterol number of 240 mg/dL or above. Someone has borderline cholesterol, meanwhile, when their total cholesterol is in th...
Source: TIME: Health - April 1, 2024 Category: Consumer Health News Authors: Sarah Klein Tags: Uncategorized Evergreen freelance healthscienceclimate Source Type: news
